-
Taxonomy & unit
-
us-gaap: GBP/shares and USD/shares
-
Description
-
Face amount or stated value per share of common stock.
-
Summary
-
Achilles Therapeutics plc quarterly Common Stock, Par or Stated Value Per Share history and growth rate from Q4 2020 to Q2 2024.
- Achilles Therapeutics plc Common Stock, Par or Stated Value Per Share for the quarter ending June 30, 2024 was 0 GBP/shares, unchanged year-over-year.
Common Stock, Par or Stated Value Per Share, Quarterly (GBP/shares)
Common Stock, Par or Stated Value Per Share, YoY Quarterly Growth (%)